Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases

by Steiner, P., Hora, M., Stehlik, J., Martinek, P., Vanecek, T., Petersson, F., Michal, M., Korabecna, M., Travnicek, I., Hes, O.
Published 2016